The venture was found in Asia in China. The main office of represented VC is situated in the Shenzhen.
Considering the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars.
The current fund was established by Jiaxi Lin.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cheng Guang, Sandbox Network Technology, Mad Science. Among the most successful fund investment fields, there are EdTech, Medical.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Guojin Capital, startups are often financed by iDreamsky Technology, Zhuhai High Tech Investment, Trustbridge Partners. The meaningful sponsors for the fund in investment in the same round are iDreamsky Technology, Zhuhai High Tech Investment, Zero2IPO Ventures. In the next rounds fund is usually obtained by iDreamsky Technology, ZhenFund, Zero2IPO Ventures.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Alebund Pharmaceuticals | $30M | 12 Apr 2023 | Shanghai, China | ||
Dshifu | $1M | 01 Apr 2021 | Dongcheng District, Beijing, China | ||
$7M | 05 Aug 2019 | Yuexiu District, Guangdong Province | |||
Sandbox Network Technology | $15M | 22 Jul 2019 | Xiangzhou District, Guangdong Province | ||
Sandbox Network Technology | 29 Aug 2018 | Xiangzhou District, Guangdong Province, China | |||
Fangti.com | $1M | 31 Jul 2018 | China, Dongcheng District | ||
Mad Science | $15M | 29 Jun 2018 | Shanghai, China | ||
$3M | 29 May 2018 | China, Beijing | |||
Jianmian | $1M | 28 May 2018 | Futian District, Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Alebund Pharmaceuticals | $30M | 12 Apr 2023 | Shanghai, China | ||
Dshifu | $1M | 01 Apr 2021 | Dongcheng District, Beijing, China | ||
$7M | 05 Aug 2019 | Yuexiu District, Guangdong Province | |||
Sandbox Network Technology | $15M | 22 Jul 2019 | Xiangzhou District, Guangdong Province | ||
Sandbox Network Technology | 29 Aug 2018 | Xiangzhou District, Guangdong Province, China | |||
Fangti.com | $1M | 31 Jul 2018 | China, Dongcheng District | ||
Mad Science | $15M | 29 Jun 2018 | Shanghai, China | ||
$3M | 29 May 2018 | China, Beijing | |||
Jianmian | $1M | 28 May 2018 | Futian District, Guangdong Province |